Montagna L - Search Results

1

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin.

Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF. Derosa G, et al. Among authors: montagna l. Intern Med J. 2007 Feb;37(2):79-86. doi: 10.1111/j.1445-5994.2007.01238.x. Intern Med J. 2007. PMID: 17229249 Clinical Trial.

2

Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion.

Emanuele E, Falcone C, Carabela M, Minoretti P, D'Angelo A, Montagna L, Geroldi D. Emanuele E, et al. Among authors: montagna l. Int J Mol Med. 2003 Oct;12(4):509-12. Int J Mol Med. 2003. PMID: 12964027

3

Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.

Emanuele E, Peros E, Minoretti P, Falcone C, D'Angelo A, Montagna L, Geroldi D. Emanuele E, et al. Among authors: montagna l. BMC Cardiovasc Disord. 2003 Dec 12;3:12. doi: 10.1186/1471-2261-3-12. BMC Cardiovasc Disord. 2003. PMID: 14670093 Free PMC article.

4

Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.

Peros E, Geroldi D, D'Angelo A, Falcone C, Montagna L, Carabela M, Emanuele E. Peros E, et al. Among authors: montagna l. Int J Mol Med. 2004 Feb;13(2):243-7. Int J Mol Med. 2004. PMID: 14719130

5

Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patients.

Emanuele E, Lusignani LS, Peros E, Montagna G, D'Angelo A, Montagna L, Geroldi D. Emanuele E, et al. Among authors: montagna g, montagna l. Am J Nephrol. 2004 Mar-Apr;24(2):221-9. doi: 10.1159/000077293. Epub 2004 Mar 12. Am J Nephrol. 2004. PMID: 15017119

6

Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.

Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, D'Angelo A, Montagna L, Bruni AC, Geroldi D. Emanuele E, et al. Among authors: montagna l. Neurosci Lett. 2004 Feb 26;357(1):45-8. doi: 10.1016/j.neulet.2003.12.043. Neurosci Lett. 2004. PMID: 15036610

7

Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease.

Emanuele E, Peros E, Scioli GA, D'Angelo A, Olivieri C, Montagna L, Geroldi D. Emanuele E, et al. Among authors: montagna l. Int J Mol Med. 2004 Jun;13(6):849-53. Int J Mol Med. 2004. PMID: 15138623

8

Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.

Emanuele E, Peros E, Minoretti P, D'Angelo A, Montagna L, Falcone C, Geroldi D. Emanuele E, et al. Among authors: montagna l. Clin Chim Acta. 2004 Dec;350(1-2):159-65. doi: 10.1016/j.cccn.2004.07.023. Clin Chim Acta. 2004. PMID: 15530473

9

Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.

Emanuele E, Peros E, Minoretti P, D'Angelo A, Piccinni MN, Montagna L, Geroldi D. Emanuele E, et al. Among authors: montagna l. Nutr Metab Cardiovasc Dis. 2004 Aug;14(4):193-9. doi: 10.1016/s0939-4753(04)80004-8. Nutr Metab Cardiovasc Dis. 2004. PMID: 15553596

10

Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride.

Derosa G, Cicero AF, Dangelo A, Gaddi A, Ragonesi PD, Piccinni MN, Salvadeo S, Ciccarelli L, Pricolo F, Ghelfi M, Ferrari I, Montagna L, Fogari R. Derosa G, et al. Among authors: montagna l. Hypertens Res. 2005 Nov;28(11):917-24. doi: 10.1291/hypres.28.917. Hypertens Res. 2005. PMID: 16555581 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters